|
US4099012A
(en)
|
1975-08-28 |
1978-07-04 |
Ciba-Geigy Corporation |
2-pyrazolyl-benzophenones
|
|
NZ192803A
(en)
|
1979-02-07 |
1984-08-24 |
Hoffmann La Roche |
Pyrimido-2-benzazepines and pharmaceutical compositions
|
|
US4481142A
(en)
|
1979-02-07 |
1984-11-06 |
Hoffmann-La Roche Inc. |
Pyrimido-2-benzazepines
|
|
US4469633A
(en)
|
1980-05-16 |
1984-09-04 |
Hoffmann-La Roche Inc. |
N-oxides of 5-oxo-1-phenyl-2-benzazepines
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
EP0273697A3
(en)
|
1986-12-30 |
1989-11-29 |
Merck & Co. Inc. |
2-benzazepines with 5- and 6- membered heterocyclic rings
|
|
IL85035A0
(en)
|
1987-01-08 |
1988-06-30 |
Int Genetic Eng |
Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
|
|
US5166151A
(en)
|
1988-03-25 |
1992-11-24 |
Merck & Co., Inc. |
2-Benzazepines with 5- and 6-membered heterocyclic rings, compositions and medical methods of use thereof
|
|
US5210082A
(en)
|
1991-05-16 |
1993-05-11 |
Merck & Co., Inc. |
2-benzazepines with 5- and 6-membered heterocyclic rings to treat pain and anxiety disorders
|
|
US5736137A
(en)
|
1992-11-13 |
1998-04-07 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
|
US5747487A
(en)
*
|
1993-07-29 |
1998-05-05 |
American Cyanamid Company |
Tricyclic benzazepine vasopressin antagonists
|
|
US5595721A
(en)
|
1993-09-16 |
1997-01-21 |
Coulter Pharmaceutical, Inc. |
Radioimmunotherapy of lymphoma using anti-CD20
|
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
EP0888350A1
(en)
|
1996-03-08 |
1999-01-07 |
Zeneca Limited |
Azolobenzazepine derivatives as neurologically active agents
|
|
EP0946523A1
(en)
|
1996-12-23 |
1999-10-06 |
Celltech Therapeutics Limited |
Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
|
|
GB9713087D0
(en)
|
1997-06-20 |
1997-08-27 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
ES2191963T3
(es)
|
1997-09-29 |
2003-09-16 |
Meiji Seika Kaisha |
Derivados triciclicos de triazolobenzazepina, proceso para la obtencion de los mismos y agentes antialergicos.
|
|
US6277844B1
(en)
|
1998-09-14 |
2001-08-21 |
Sydney Spector |
Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis
|
|
US6417207B1
(en)
|
1999-05-12 |
2002-07-09 |
Nitromed, Inc. |
Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
|
|
AU784971B2
(en)
*
|
1999-08-11 |
2006-08-10 |
Biogen Inc. |
Treatment of patients having non-Hodgkins lymphoma with bone marrow involvement with anti-CD20 antibodies
|
|
CA2390412A1
(en)
*
|
1999-11-08 |
2001-05-17 |
Idec Pharmaceuticals Corporation |
Treatment of b cell malignancies using anti-cd40l antibodies in combination with anti-cd20 antibodies and/or chemotherapeutics and radiotherapy
|
|
WO2001052353A2
(en)
*
|
2000-01-12 |
2001-07-19 |
Emag Technologies L.L.C. |
Low cost compact omni-directional printed antenna
|
|
AU2001259142C1
(en)
*
|
2000-04-25 |
2006-11-23 |
Biogen Idec Inc. |
Intrathecal administration of rituximab for treatment of central nervous system lymphomas
|
|
US6989385B2
(en)
|
2000-12-21 |
2006-01-24 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
US6686352B2
(en)
|
2001-05-18 |
2004-02-03 |
Hoffmann-La Roche Inc. |
Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives
|
|
JP4364637B2
(ja)
|
2001-08-09 |
2009-11-18 |
アクテリオン ファーマシューティカルズ リミテッド |
新規なベンゾ縮合へテロ環化合物
|
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
|
GB0226583D0
(en)
|
2002-11-14 |
2002-12-18 |
Cyclacel Ltd |
Compounds
|
|
SI1847539T1
(sl)
|
2002-12-24 |
2010-01-29 |
Astrazeneca Ab |
Kinazolinski derivati
|
|
EP1599202A1
(en)
|
2003-02-17 |
2005-11-30 |
Pharmacia Italia S.p.A. |
Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
TWI372050B
(en)
|
2003-07-03 |
2012-09-11 |
Astex Therapeutics Ltd |
(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
|
|
GB0315657D0
(en)
|
2003-07-03 |
2003-08-13 |
Astex Technology Ltd |
Pharmaceutical compounds
|
|
US7141568B2
(en)
|
2003-07-09 |
2006-11-28 |
Pfizer Italia S.R.L. |
Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
US20050025605A1
(en)
*
|
2003-07-30 |
2005-02-03 |
Vrana John J. |
Locator stud and method of assembly
|
|
ATE506953T1
(de)
|
2003-08-07 |
2011-05-15 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidindiamin-verbindungen und verwendungen als antiproliferative mittel
|
|
CN1897950A
(zh)
|
2003-10-14 |
2007-01-17 |
惠氏公司 |
稠合芳基和杂芳基衍生物及其使用方法
|
|
AU2005243175B2
(en)
*
|
2004-05-14 |
2011-12-01 |
Millennium Pharmaceuticals, Inc. |
Compounds and methods for inhibiting mitotic progression by inhibition of Aurora kinase
|
|
US7754714B2
(en)
|
2004-05-18 |
2010-07-13 |
Rigel Pharmaceuticals, Inc. |
Cycloalkyl substituted pyrimidinediamine compounds and their uses
|
|
US9228008B2
(en)
*
|
2004-05-28 |
2016-01-05 |
Idexx Laboratories, Inc. |
Canine anti-CD20 antibodies
|
|
JP2008505167A
(ja)
|
2004-07-05 |
2008-02-21 |
アステックス、セラピューティックス、リミテッド |
医薬組成物
|
|
MX2007000631A
(es)
|
2004-07-16 |
2007-03-30 |
Sunesis Pharmaceuticals Inc |
Tienopirimidinas utiles como inhibidores de aurora cinasa.
|
|
ATE421996T1
(de)
|
2004-11-15 |
2009-02-15 |
Rigel Pharmaceuticals Inc |
Verfahren zur herstellung optisch aktiver n- carbamat-geschützter beta-lactame durch optische auflösung unter verwendung einer candida antarctica lipase
|
|
GB2420559B
(en)
|
2004-11-15 |
2008-08-06 |
Rigel Pharmaceuticals Inc |
Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
|
|
CN101084214A
(zh)
|
2004-11-17 |
2007-12-05 |
迈卡纳治疗股份有限公司 |
激酶抑制剂
|
|
MX2007008008A
(es)
|
2004-12-30 |
2007-11-12 |
Astex Therapeutics Ltd |
Compuestos de pirazol que modulan la actividad de las cinasas cdk, gsk y aurora.
|
|
WO2006070202A1
(en)
|
2004-12-30 |
2006-07-06 |
Astex Therapeutics Limited |
Pyrazole derivatives having kinase modulating activity
|
|
WO2006070198A1
(en)
|
2004-12-30 |
2006-07-06 |
Astex Therapeutics Limited |
Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases
|
|
JP2008526721A
(ja)
|
2004-12-30 |
2008-07-24 |
アステックス、セラピューティックス、リミテッド |
Ｃｄｋ、ｇｓｋ及びオーロラキナーゼの活性を調節するチアゾールおよびイソチアゾール誘導体
|
|
US7485661B2
(en)
|
2005-01-18 |
2009-02-03 |
Pfizer Italia S.R.L. |
Heterobicyclic pyrazole derivatives as kinase inhibitors
|
|
US20070104785A1
(en)
*
|
2005-07-29 |
2007-05-10 |
Navale Suryakant V |
Tablets of linezolid form iii and processes for their preparation
|
|
KR101487027B1
(ko)
|
2005-09-30 |
2015-01-28 |
미카나 테라퓨틱스, 인크. |
치환된 피라졸 화합물
|
|
MX2008005814A
(es)
|
2005-11-03 |
2008-10-15 |
Vertex Pharma |
Aminopirimidinas utiles como inhibidores de cinasa.
|
|
EA200870117A1
(ru)
*
|
2005-12-23 |
2008-12-30 |
Смитклайн Бичам Корпорейшн |
Азаиндоловые ингибиторы аурора-киназ
|
|
CN100346830C
(zh)
*
|
2005-12-28 |
2007-11-07 |
上海交通大学医学院附属瑞金医院 |
一种治疗b细胞淋巴瘤的药物组合物
|
|
CN101379060B
(zh)
*
|
2006-02-10 |
2012-05-23 |
转化技术制药公司 |
作为Aurora激酶抑制剂的苯并唑系衍生物、组合物和使用方法
|
|
TW200808311A
(en)
|
2006-03-30 |
2008-02-16 |
Nerviano Medical Sciences Srl |
Use of a kinase inhibitor for the treatment of particular resistant tumors
|
|
GB0609530D0
(en)
|
2006-05-12 |
2006-06-21 |
Cyclacel Ltd |
Combination
|
|
WO2007132221A1
(en)
|
2006-05-12 |
2007-11-22 |
Cyclacel Limited |
Combined anticancer pyrimidine-thiazole aurora kinase inhibitors
|
|
WO2007132220A1
(en)
|
2006-05-12 |
2007-11-22 |
Cyclacel Limited |
Combination of a 2-substituted-4-heter0aryl-pyrimidine amine with a cytotoxic drug and use thereof in the treatment of a proliferative disorder
|
|
JP2009542664A
(ja)
*
|
2006-06-30 |
2009-12-03 |
シェーリング コーポレイション |
Ｐ５３活性を増大させる置換されたピペリジンの使用の方法
|
|
US7718648B2
(en)
*
|
2006-08-09 |
2010-05-18 |
Millennium Pharmaceuticals, Inc. |
Pyridobenzazepine compounds and methods for inhibiting mitotic progression
|
|
CL2007003244A1
(es)
*
|
2006-11-16 |
2008-04-04 |
Millennium Pharm Inc |
Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
|
|
US20090023743A1
(en)
*
|
2007-05-09 |
2009-01-22 |
Abbott Laboratories |
Inhibitors of protein kinases
|
|
US20090203671A1
(en)
|
2007-11-27 |
2009-08-13 |
Abbott Laboratories |
Method of treating cancer
|
|
WO2009114703A2
(en)
*
|
2008-03-12 |
2009-09-17 |
Fox Chase Cancer Center |
Combination therapy for the treatment of cancer
|
|
RU2535032C2
(ru)
|
2008-12-22 |
2014-12-10 |
Милленниум Фармасьютикалз, Инк. |
Сочетание ингибиторов аврора киназы и анти-cd 20 антител
|
|
JO3635B1
(ar)
*
|
2009-05-18 |
2020-08-27 |
Millennium Pharm Inc |
مركبات صيدلانية صلبة وطرق لانتاجها
|
|
JO3434B1
(ar)
*
|
2009-07-31 |
2019-10-20 |
Millennium Pharm Inc |
مركبات صيدلانية لمعالجة السرطان وامراض واضطرابات اخري
|
|
BR112012020557A8
(pt)
*
|
2010-02-19 |
2018-01-02 |
Millennium Pharm Inc |
formas cristalinas de 4-{[9-cloro-7-(2-flúor-6-metoifenil)-5h-pirimido[5,4-d][2]benzazepin-2-il]amino}-2-metoxibenzoato de sódio
|